Biostar Pharmaceuticals, Inc. (BSPM)

[v80alue]

BSPM. The regulation is a draft which only applies to Shaan Xi province so one can almost safely say the suspension will be limited within the province, not any other region. BSPM 10k has no breakdown based on region for Aoxing. The regulation does not say anything about how one can resume sales with what kinda modification to their advertisement. In all, it is hard to judge the damage in short term or intermediate term.

One similar example is CBPO earlier this year. It dropped precipitously after short attack (with seemingly strong fact based blog) from 11 to low of 7.5. Look at where it is today.

Sentiment: I would expect a PR from the company about how it will address this and to what extent this will affect their sales etc. Short term it seems to be affected for sure but I don't expect a lasting, permanent damage at this time of yet. Again based the experience with CBPO, the selling stopped at 200MA. It seems to be too late to sell it right now. It could even be good buy if company handles it correctly.